Post Categories
QPS Aids Development of Cannabinoid Chewing Gum, for MS Patients
August 11, 2015
Cannabinoid bioscience has come a long way. New York-based Axim Biotech is at the forefront, developing – among many other, related products – a…
Mental Vacation
August 11, 2015
Need a vacation? Don’t have time? Spend the next 45 seconds pretending you’re here….
Fast Track Routes for Medicines that address Unmet Medical Needs
July 27, 2015
Launch of two-month public consultations on revised guidelines on accelerated assessment and conditional marketing authorization The European Medicines Agency (EMA) has revised its guidelines…
Sports Nutrition Leadership, Benchtop to Countertop: Watch the Webinar on Building Better Beverages with panelist Doug Kalman, Director of Nutrition & Endocrinology at QPS MRA
July 29, 2015
Finding something tasty to drink at the mini-mart has gotten really complicated lately. Knowing the usual soft drinks are unhealthy, you may be tempted…
DMPK scientists from Exelixis and QPS publish on “Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites” in DMD
July 27, 2015
Read the original Exelexis-supported publication in Drug Metabolism & Disposition (DMD). Cabozantinib (COMETRIQ®) inhibits the activity of tyrosine kinases including MET, VEGFRs and RET….
Dr. Diane Krieger from QPS MRA acknowledged in NEJM for her role as investigator in the SCALE Obesity and Prediabetes Study Group
July 27, 2015
The sheer abundance of diet drugs available suggests two things: 1) there is a huge market for them and 2) none of them work…
Hop on the QPS Bioanalysis Bus: Protein Quantitation by LC-MS/MS is Just Around the Corner
July 24, 2015
We love it when you notice! At the recent Sciex Users gathering of MS geeks in the 63th ASMS Annual Conference, one member of…
Regulatory Expertise Now Part of QPS Clinical Development Offerings
July 9, 2015
In July 2015, regulatory expert Patricia Baede joined QPS’ clinical development teams. With 20 years of experience in clinical trial conduct and all regulatory…
War in Ukraine Impacts Clinical Research Industry
May 18, 2022
Russia’s invasion of Ukraine is causing what the Financial Times called a “many-sided economic shock,” sending global prices sky-high for goods ranging from fuel…
Can LSD Be a Valuable Therapeutic Agent for Anxiety and Depression?
May 16, 2022
The World Health Organization has estimated that the COVID-19 pandemic led to a 25% increase in cases of anxiety disorder worldwide in 2020. As…
Shedding Light on the Dark Proteome
May 9, 2022
More than 20 years ago when researchers shared the human genome sequence, the same scientists counted 20,000 discrete sections, approximately 1% of our DNA,…
3D DNA: Imaging and Sequencing Finally Reveal Genomic Structure
May 2, 2022
Ever since German anatomist Walther Flemming discovered chromosomes in the mid-1800s, scientists have been actively working to decipher the complex organization of these threadlike…
Novel Approaches to Treating Depression
April 27, 2022
Suicide is the second leading cause of death among Americans between the ages of 10 and 34, per the Centers for Disease Control and…
Lab-Grown Fish: Swimming into Sustainability
April 20, 2022
It seems impossible to discuss the fishing industry without also discussing the harm caused by overfishing, overburdened waterways, and concerns about mercury contamination. But…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
